Idorsia Pharmaceuticals US Inc

Active trials

• phase2Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disordercompletedn=166
• —Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®recruitingn=785
• phase3A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Diseaseactive not recruitingn=107
• —Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)active not recruitingn=2,095
• phase1A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjectscompletedn=37
• phase1A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjectscompletedn=39
• phase4A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturiacompletedn=60
• phase1A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptivescompletedn=19